ONCOCYTE REPORTS Full Year 2023 FINANCIAL RESULTS

Conference Call on Friday, April 12, 2024 at 5:00 a.m. PT / 8:00 a.m. ET

Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules

ONCOCYTE REPORTS Full Year 2023 FINANCIAL RESULTS

Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules

Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay

Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay

Auto Parts 4 Less Group Inc. Announces Strategic Investment from RB Capital to Fuel Growth and Innovation

Auto Parts 4 Less Group Inc. Announces Strategic Investment from RB Capital to Fuel Growth and Innovation

SS Innovations’ Flagship SSi Mantra Surgical Robotic Device Successfully Completes Telesurgery Procedures

First-ever telesurgery using SSi Mantra performed on an animal in India

SS Innovations’ Flagship SSi Mantra Surgical Robotic Device Successfully Completes Telesurgery Procedures

ONCOCYTE TO ANNOUNCE FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS

Conference Call and Webcast on Friday, April 12, 2024, at 5:00 a.m. PT / 8:00 a.m. ET

ONCOCYTE TO ANNOUNCE FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS